Our team

+55 (21) 3981-0080

Paula Couto

Attorney

Intellectual Property Attorney with over eight years of experience in Intellectual Property, focusing on strategic patent litigation and advising multinational companies, particularly in the pharmaceutical, biotechnology and agrochemical sectors. Her practice is primarily dedicated to patent disputes, including infringement and invalidity lawsuits, preliminary injunctions, enforcement strategies and strategic legal counseling throughout the product lifecycle. She also advises clients on regulatory matters involving ANVISA, with a focus on the intersection between intellectual property and regulatory issues in Brazil. In addition, she has experience in trademarks, unfair competition, copyright, information technology, intellectual property agreements, administrative proceedings before the Brazilian PTO (INPI) and research, development, and innovation (R&D) projects.

Associations
  • INTA – Member of the International Trademark Association Patent Committee
Areas and industries
  • Patent Litigation
  • Patents
  • Life Sciences
  • Trademarks
  • Regulatory Affairs
  • Unfair Competition
  • Technology
Formation
  • Postgraduate degree in Civil Law and Litigation from FGV DIREITO SP
  • Postgraduate degree in Intellectual Property Law from Pontifical Catholic University of Rio de Janeiro (PUC RIO)
  • Bachelor of Laws from Pontifical Catholic University of Rio de Janeiro (PUC RIO)
Publications

From Exclusivity to Public Access in Rio de Janeiro: Weight-Loss Injection Pens and the Brazilian Health System (SUS)Migalhas, March 12, 2026

The Hard 20-Year Ozempic Patent Term Cap and Brazil’s Message to Pharma CompaniesIAM, February 16, 2026

Bills No. 160/26 and 68/26 and Their Impact on the Legal Certainty of Pharmaceutical Patents in BrazilMigalhas, February 16, 2026

“The BPTO’s New Guidelines Significantly Limited the Possibility of Amending Patent Claims”Leaders League, August 29, 2025

Reflections on the Brazilian Superior Court of Justice’s Recent Decision on Pharmaceutical AdvertisingDi Blasi, Parente & Associates, December 18, 2024

ESG and Intellectual Property: Sustainability and the Green Patents Fast-Track Program – Chapter in the book ESG: Legal Reflections for Its Understanding, developed by the International Relations Committee of the São Paulo Bar Association (OAB/SP), May 29, 2023

Pharmaceutical Patents, Access to Healthcare, and the Economic OrderMigalhas, 2022

Languages

English

Spanish

Portuguese